SCHEMBL1807327

SCHEMBL1807327

COc1cc(CF)c(S(N)(=O)=O)cc1Nc1ncnc2cc(OC)c(OC)cc12

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 3/20 0.57
KDR P35968 9/20 0.53
RET P07949 9/20 0.53
KIF5B P33176 7/20 0.53
EGFR P00533 6/20 0.52
FLT1 P17948 3/20 0.52
FGFR1 P11362 2/20 0.51
BRAF P15056 1/20 0.50
TNNI3K Q59H18 1/20 0.50
RIPK2 O43353 1/20 0.50
SRC P12931 1/20 0.50
NOD1 Q9Y239 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1808469 0.91 BRAF (0.61) ENPP1KDRRETKIF5BEGFR
SCHEMBL1807986 0.82 BRAF (0.52) ENPP1KDREGFRBRAFTNNI3K
SCHEMBL5652266 0.78 EGFR (0.63) KDRRETKIF5BEGFRFLT1
SCHEMBL6911482 0.76 KDR (0.60) KDRRETKIF5BEGFRFLT1
SCHEMBL1804984 0.75 TNNI3K (0.62) ENPP1EGFRBRAFTNNI3KSRC
Hydrochloric Acid SCHEMBL12003797 0.75 EGFR (0.60) KDRRETKIF5BEGFRFLT1
SCHEMBL1806890 0.73 BRAF (0.59) ENPP1KDRRETKIF5BEGFR
SCHEMBL23762278 0.73 ENPP1 (1.00) ENPP1EGFR
SCHEMBL12227578 0.71 RET (0.70) KDRRETKIF5BEGFRFLT1
SCHEMBL5864588 0.71 EGFR (0.67) KDRRETKIF5BEGFRFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP claimed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO claimed
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP disclosed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO disclosed